Journals / MN Kardiyoloji / 2018 / Cilt: 25 - Sayı: 3

Novel Inflammatory Indicator in Calsific Aortic Valve Stenosis: Monocyte to HDL-Cholesterol Ratio

Kalsifik Aort Darlığının Yeni Bir Enflamatuvar İndikatörü: Monosit/Yüksek Yoğunluklu Lipoprotein Kolesterol Oranı

Pages
108–114
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, MHR was significantly increased in parallel with the severity of aortic stenosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Calcific aortic valve stenosis is a progressive chronic disease like atherosclerosis and characterized by mechanical stress, en- dothelial damage, lipid accumulation, calcification and inflammation.
📊
Key Findings & Data:Material and Method: A total of 177 consecutive patients with calcific aortic valve stenosis and 101 controls were enrolled into the study.
💡
Conclusion & Impact:In addition, MHR was significantly increased in parallel with the severity of aortic stenosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Calcific aortic valve stenosis is a progressive chronic disease like atherosclerosis and characterized by mechanical stress, en- dothelial damage, lipid accumulation, calcification and inflammation. Recently, monocyte count to HDL-C ratio (MHR) has emerged as a new inflammatory cardiovascular prognostic marker in chronic kidney disease and cardiac disorders. The aim of the study was to eval- uate the relationship between MHR and calcific aortic valve stenosis. Material and Method: A total of 177 consecutive patients with calcific aortic valve stenosis and 101 controls were enrolled into the study. Demographical, clinical and laboratory parameters of all participants were recorded. MHR was calculated from complete blood count. Results: MHR was significantly increased in parallel to the severity of aortic stenosis (51.5 ± 23.4 in control group, 77.1 ± 18.6 in the mild-to-moderate calcific aortic valve stenosis group and 108.7 ± 43.0 in the severe calcific aortic valve stenosis group, p<0.001). Also, there was significiant positive correlation between MHR and maximum systolic transaortic gradient (r= 0.355, p<0.001) and mean sys- tolic transaortic gradient (r=0.379, p<0.001). MHR level was found significantly and independently associated with the aortic stenosis (OR: 1.076, 95% CI: 1.058-1.120, p=0.001). Conclusion: Our findings confirmed that MHR was significantly higher in patients with calcific aortic valve stenosis. We found that MHR was significantly higher in patients with severe calcific aortic valve stenosis than control subjects and patients with mild-to-moderate calcific aortic valve stenosis. In addition, MHR was significantly increased in parallel with the severity of aortic stenosis.

Özet

Amaç: Kalsifik aort kapak darlığı, ateroskleroz gibi ilerleyici bir kronik hastalıktır ve mekanik stres, endotel hasarı, lipid birikimi, kalsifi- kasyon ve enflamasyon ile karakterizedir. Son zamanlarda, monosit sayısının yüksek yoğunluklu lipoprotein kolesterol değerine oranı (MHO), kronik böbrek hastalığı ve kardiyak bozukluklarda yeni bir enflamatuear kardiyovasküler prognostik belirteç olarak ortaya çık- mıştır. Çalışmanın amacı MHO ve kalsifik aort kapak darlığı arasındaki ilişkiyi değerlendirmektir. Gereç ve Yöntem: Toplam 177 ardışık kalsifik aort kapak darlığı ve 101 kontrol grubu çalışmaya alındı. Tüm katılımcıların demografik, klinik ve laboratuvar parametreleri kaydedildi. MHO tam kan sayımı ile hesaplandı. Bulgular: MHO, aort stenozunun şiddetine (kontrol grubunda 51,5 ± 23,4, hafif-orta kalsifik aort kapak darlığı grubunda 77,1 ± 18,6 ve şiddetli kalsifik aort kapak darlığı grubunda 108,7 ± 43,0) göre anlamlı şekilde arttı (p <0,001). MHO ile maksimum sistolik transaortik gradiyent (r = 0,355, p <0,001) ve ortalama sistolik transaortik gradient (r=0,379, p <0,001) arasında anlamlı bir pozitif korelasyon var- dı. MHO düzeyi aort darlığı ile anlamlı ve bağımsız olarak ilişkili bulundu (OR: 1,076, 95% CI: 1,058-1,120, p=0,001). Sonuç: Bulgularımız MHO'nun kalsifik aort kapak darlığı hastalarda belirgin olarak yüksek olduğunu doğruladı. Şiddetli kalsifik aort ka- pak darlıklı hastalarda MHO'nun kontrol grubundan ve hafif-orta kalsifik aort kapak darlığı hastalardan daha yüksek olduğunu bulduk. Ayrıca, aort darlığının şiddetine paralel olarak MHO de anlamlı şekilde arttığı görüldü.

🔖

Cite This Article

ÜNAL, S., YAYLA, Ç., YAYLA, K. G., AÇAR, B., KUYUMCU, M. S., ERTEM, A. G., TEMİZHAN, A. (2018). Novel Inflammatory Indicator in Calsific Aortic Valve Stenosis: Monocyte to HDL-Cholesterol Ratio. MN Kardiyoloji, Cilt: 25 - Sayı: 3, 108–114. https://ajindex.com/articles/297241

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368:1005-11.
  2. Otto CM, Kuusisto J, Reichenbach DD, et al. Charac teri - zation of the early lesion of “degenerative” valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-53.
  3. O'Brien KD, Reichenbach DD, Marcovina SM, et al. Apoli - pop roteins B, (a), and E accumulate in the morphologically early lesion of “degenerative” valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996;16:523-32.
  4. Mohty D, Pibarot P, Despres JP, et al. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol 2008;28:187-93. Yildirir A. Valvular heart disease associated with coronary artery disease. Anadol Kardiyol Derg 2009;9 Suppl 1:10-6. Dimitrow PP. Aortic stenosis: new pathophysiological mechanisms and their therapeutic implications. Polskie Archiwum Medycyny Wewnetrznej 2014;124:723-30.
  5. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011;11:762-74.
  6. Trapeaux J, Busseuil D, Shi Y, et al. Improvement of aortic valve stenosis by ApoA-I mimetic therapy is associated with decreased aortic root and valve remodelling in mice. Br J Pharmacol 2013;169:1587-99.
  7. Kanbay M, Solak Y, Unal HU, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol 2014;46:1619-25.
  8. Canpolat U, Cetin EH, Cetin S, et al. Association of Mo -nocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation. Clin Appl Thromb Hemost 2015;22:476-82.
  9. Canpolat U, Aytemir K, Yorgun H, et al. The role of prepro- cedural monocyte-to-high-density lipoprotein ratio in pre- diction of atrial fibrillation recurrence after cryoballoon- based catheter ablation. Europace 2015;7:1807-15.
  10. Cetin EH, Cetin MS, Canpolat U, et al. Monocyte/HDL-cho- lesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-seg- ment elevation myocardial infarction. Biomark Med 2015;9:967-77.
  11. Gayretli Yayla K, Canpolat U, Yayla Ç, et al. A Novel Marker of Impaired Aortic Elasticity in Never Treated Hypertensive Patients: Monocyte/HDL Cholesterol Ratio. Acta Cardiol Sin 2017:33;41-9.
  12. American College of C, American Heart Association Task Force on Practice G, Society of Cardiovascular A, Bonow RO, Carabel